Adial Pharmaceuticals, Inc. (AZR) stock
AZRNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ADIL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Oct 21, 2026Score 5/30
Share price
Not available yet
Price, market cap and P/E appear here once daily prices are connected.
Adial Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Adial Pharmaceuticals's cash was $28.71M at Jun 30, 2026. For fiscal 2025 it was $5.88M, up 56.8% from the year before. The highest annual figure on record is $6.78M in fiscal 2019.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.88M | +56.8% |
| FY2024 | Dec 31, 2024 | $3.75M | +32.7% |
| FY2023 | Dec 31, 2023 | $2.83M | -29.4% |
| FY2022 | Dec 31, 2022 | $4.00M | -34.0% |
| FY2021 | Dec 31, 2021 | $6.06M | +37.7% |
| FY2020 | Dec 31, 2020 | $4.40M | -35.1% |
| FY2019 | Dec 31, 2019 | $6.78M | +75.2% |
| FY2018 | Dec 31, 2018 | $3.87M | +21102.6% |
| FY2017 | Dec 31, 2017 | $18.25K | -79.3% |
| FY2016 | Dec 31, 2016 | $87.99K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $28.71M | +385.4% |
| Q1 FY2026 | Mar 31, 2026 | $4.58M | +93.8% |
| Q4 FY2025 | Dec 31, 2025 | $5.88M | +56.8% |
| Q3 FY2025 | Sep 30, 2025 | $4.61M | -11.5% |
| Q2 FY2025 | Jun 30, 2025 | $5.92M | +79.9% |
| Q1 FY2025 | Mar 31, 2025 | $2.37M | -52.9% |
| Q4 FY2024 | Dec 31, 2024 | $3.75M | +32.7% |
| Q3 FY2024 | Sep 30, 2024 | $5.20M | +1547.6% |
| Q2 FY2024 | Jun 30, 2024 | $3.29M | +169.9% |
| Q1 FY2024 | Mar 31, 2024 | $5.03M | +117.3% |
| Q4 FY2023 | Dec 31, 2023 | $2.83M | -29.4% |
| Q3 FY2023 | Sep 30, 2023 | $315.88K | -94.5% |
| Q2 FY2023 | Jun 30, 2023 | $1.22M | -86.7% |
| Q1 FY2023 | Mar 31, 2023 | $2.31M | -81.8% |
| Q4 FY2022 | Dec 31, 2022 | $4.00M | -34.0% |
| Q3 FY2022 | Sep 30, 2022 | $5.75M | -19.9% |
| Q2 FY2022 | Jun 30, 2022 | $9.16M | +75.8% |
| Q1 FY2022 | Mar 31, 2022 | $12.69M | +125.1% |
| Q4 FY2021 | Dec 31, 2021 | $6.06M | +37.7% |
| Q3 FY2021 | Sep 30, 2021 | $7.18M | -2.5% |
| Q2 FY2021 | Jun 30, 2021 | $5.21M | -39.6% |
| Q1 FY2021 | Mar 31, 2021 | $5.64M | +13.9% |
| Q4 FY2020 | Dec 31, 2020 | $4.40M | -35.1% |
| Q3 FY2020 | Sep 30, 2020 | $7.37M | -13.7% |
| Q2 FY2020 | Jun 30, 2020 | $8.62M | -15.9% |
| Q1 FY2020 | Mar 31, 2020 | $4.95M | -56.5% |
| Q4 FY2019 | Dec 31, 2019 | $6.78M | +75.2% |
| Q3 FY2019 | Sep 30, 2019 | $8.53M | +77.1% |
| Q2 FY2019 | Jun 30, 2019 | $10.25M | +6734.8% |
| Q1 FY2019 | Mar 31, 2019 | $11.39M | +21013.4% |
| Q4 FY2018 | Dec 31, 2018 | $3.87M | +21102.6% |
| Q3 FY2018 | Sep 30, 2018 | $4.82M | +11837.3% |
| Q2 FY2018 | Jun 30, 2018 | $150.03K | +9.4% |
| Q1 FY2018 | Mar 31, 2018 | $53.97K | -38.7% |
| Q4 FY2017 | Dec 31, 2017 | $18.25K | – |
| Q3 FY2017 | Sep 30, 2017 | $40.35K | – |
| Q2 FY2017 | Jun 30, 2017 | $137.13K | – |
| Q4 FY2016 | Dec 31, 2016 | $87.99K | – |